China AI drug-design deals swell as US scrutiny mounts
Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite…
China AI drug-design deals swell as US scrutiny mounts
Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite…
As China’s biotech firms shift gears, can AI floor the accelerator?
A quarter featuring multiple eye-popping deals is no longer unusual for China’s pharmaceutical industry – in fact, it…